Iigama zeSigqeba seNtsholongwane
Kwiimvavanyo zeklinikhi zonyango lwesifo se-rheumatoid, iimpawu eziqhelekileyo zisetyenziselwa ukuthelekisa ukuphumelela kwamachiza e-arthritis okanye unyango lwe-arthritis, okanye ukuthelekisa esinye isilingo kwenye. Imigaqo-nkqubo, eyaziwa njenge-American College College yeRheumatology (ACR), imilinganiselo esetyenziswe phantse zonke iiphando ezipapashiweyo ezijonge ukuphumelela (ukuphumelela) zonyango kuzo zonke iintlobo zesifo se- rheumatic .
I-ACR20 yayisisethi sokuqala seenkqubo ezimiselweyo, zilandelwa kamva yi-ACR50 kunye ne-ACR70.
Ukusetyenziswa kwe-ACR Criteria
Imilinganiselo ye-ACR isetyenziselwa ukuvavanya nokuseka ukuphuculwa kwithenda okanye izibalo ezidibeneyo kunye nokuphuculwa kwezi zintathu zilandelayo:
- Isigaba esichaphazelekayo sesigaba: Ingakanani ukuvuvukala kumalungu akho njengoko kuqinisekiswe ngu-C-proactive rate or rate of sedimentation.
- Uvavanyo lokunyamezela: Indlela obona ngayo inkqubela yakho kunye nokuphendula kunyango.
- Uvavanyo lwezonyango: Oko ugqirha wakho ubona kwinkqubela yakho kunye nokuphendula unyango.
- Isantya sobuhlungu: Ubunzima obungakanani obunakho kumalungu akho nsuku zonke.
- Umbuzo wemibuzo yokukhubazeka / osebenzayo: Ingakanani i-arthritis yakho ye-rheumatoid ephazamisa ukwazi kwakho ukwenza imisebenzi yakho yemihla ngemihla.
Imilinganiselo ye-ACR ingasetyenziselwa ukunceda oogqirha ukuba baqinisekise ngokucacileyo ukuba unyango lwakho lusebenza ekuphuculeni iimpawu zakho ze-rheumatoid arthritis, nangona zihlala zisetyenziselwa ukuhlolwa kweeklinikhi.
Ukuqonda ukuba yiyiphi i-ACR20, i-ACR50, ne-ACR70 ichaza kwiiNtsholongwane zeZliniki
Iimvavanyo zonyango zibika ipesenteji yabathathi-nxaxheba abaye bafumana i-ACR20, i-ACR50 kunye ne-ACR70. Ngokomzekelo, ukuba uphando lubhengeze ukuba ama-55 eepesenti zezigulane ziphumelele kwi-ACR20, oko kuthetha ukuba iipesenti ezingama-55 zezigulane kwisifundo siphumelele ukuphuculwa kweepesenti ezingama-20 kwithenda okanye izibalo ezidibeneyo, kunye nokuphuculwa kweepesenti ezingama-20 kwizinto ezintathu ezilandelayo.
Ukuba uvavanyo lwekliniki lubonisa ukuba ama-40 eepesenti zezigulane ziphumelele kwi-ACR50, oko kuthetha ukuba iipesenti ezingama-40 zezigulane kwisifundo siphumelele ukuphuculwa kwepesenti ezingama-50 kwithenda okanye izibalo ezidibeneyo, kunye nokuphuculwa kweepesenti ezingama-50 kwizinto ezintathu ezithintekayo. Kuyafana nakwi-ACR70, kuphela ngezinga lokuphucula iipesenti ezingama-70. Ukuze izigulane zihlolwe ngokusebenzisa iimfuno ze-ACR, kufuneka zigqityile ityala leklinikhi.
I-ACR20 Ngaba i-FDA ivunywe
Ulawulo lwe-US Food and Drug Administration (FDA) lincoma ukusebenzisa i-ACR20 njengesilinganiselo sesiphumo sokhetho lwezilwanyana zamachiza ezisetyenziselwa ukunyanga i-rheumatoid arthritis. Oku kuvunywa kukhokelela ekusebenziseni okusasazeka kwe-ACR20 kwizilingo zeclini. Ngokuqhelekileyo kuthethwa nje ngokuba yi-ACR20 kuba ifuna ubuncinci ukuphucula iipesenti ezingama-20 kwimiqathango engentla.
Imithombo:
> Felson DT, Anderson JJ, uBoers M, et al. Ikholeji yaseRamerican yeRheumatology Inkcazo yokuQala Inkcazo yokuPhucula kwiRumatoid Arthritis. Arthritis & Rheumatism. 1995; 38: 727-735. i-doi: 10.1002 / ubugcisa.1780380602.
> Felson DT, MP. I-ACR20 kunye nokuchaza iNdawo yokuLondoloza ukuphendula kwiiRheumatic Diseases: Kuninzi Kwinto Enhle. Uphando lwe-arthritis kunye neyeza . 2014; 16 (1): 101. i-doi: 10.1186 / ar4428.
Johns Hopkins Isikhungo seArthritis. Izikhokelo zoLwazi lwe-ACR: I-ACR Inkcazo yokuPhucula kwiimvavanyo ze-RA. Johns Hopkins Medicine. Ukuhlaziywa kwe-Agasti 16, 2017.
I-Rocha K. I-ACR Score: Ukulinganisa i-Rheumatoid Arthritis. I-Rheumatoid Arthritis Support Network. Ukuhlaziywa kwe-Matshi 22, 2017.